Quantcast

Latest CancerVax Stories

2014-06-25 08:31:22

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Melanoma, Angiogenesis and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_melanoma_angiogenesis_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Each of these three individual parts is evaluated...

2014-06-25 08:31:10

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_lung_cancer_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to...

2014-05-12 16:29:28

SAN DIEGO, May 12, 2014 /PRNewswire/ -- MabVax Therapeutics, Inc., a privately held cancer immunotherapy company and Telik, Inc. (Nasdaq: TELK), aclinical stage oncology drug development company have entered into a definitive merger agreement. Upon closing of the transaction, MabVax and Telik will be combined into a publicly traded company focused on the development of proprietary immunotherapy-based products to diagnose and treat cancer. Under the terms of the merger agreement,...

2014-03-17 04:21:39

BLUE BELL, Pa., March 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the fourth quarter and year ended December 31, 2013. Total revenue was $1.7 million and $13.5 million for the quarter and year ended December 31, 2013, as compared to $1.1 million and $4.1 million for the same periods in 2012. Total operating expenses for the quarter and year and ended December 31, 2013, were $9.7 million and $33.0 million as compared to...

2013-06-28 23:04:20

Researchers at Roswell Park Cancer Institute have begun a phase I clinical research study to assess the safety and efficacy of a novel immunotherapy vaccine as treatment for melanoma. Buffalo, NY (PRWEB) June 28, 2013 A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related